Articles

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials

First Department of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital Cologne, Germany
Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Germany
Cochrane Haematological Malignancies Group, First Department of Internal Medicine, University Hospital Cologne, Germany
University College London (UCL) Cancer Trials Centre, UK
Department of Radiotherapy, University “La Sapienza”, Rome, Italy
University of Modena and Reggio Emilia, Modena, Italy
European Organisation of Research and Treatment of Cancer (EORTC), Brussels, Belgium
Istituto Nazionale dei Tumori, Milan, Italy
Centre de Traitement des Données du Cancéropôle Nord-Ouest, Centre François Baclesse, Caen, France
Mount Vernon Cancer Centre, Northwood, UK
Cancer Research UK Centre, University of Southampton, UK
University of Modena and Reggio Emilia, Modena, Italy;Hematology, Arcispedale S. Maria Nuova IRCCS, Reggio Emilia, Italy
University of Modena and Reggio Emilia, Modena, Italy
Cellular Biotechnology and Hematology Department, University “La Sapienza”, Rome, Italy
Medical Research Council (MRC), Clinical Trials Unit at University College London (UCL), UK
Istituto Nazionale dei Tumori, Milan, Italy
Istituto Nazionale dei Tumori, Milan, Italy
First Department of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital Cologne, Germany
Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Germany
Vol. 102 No. 10 (2017): October, 2017 https://doi.org/10.3324/haematol.2017.167478